Compare SCLX & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | STKS |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 57.1M |
| IPO Year | N/A | 2011 |
| Metric | SCLX | STKS |
|---|---|---|
| Price | $6.82 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.70 |
| AVG Volume (30 Days) | ★ 41.1K | 35.5K |
| Earning Date | 04-10-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $805,722,000.00 |
| Revenue This Year | $122.52 | $7.47 |
| Revenue Next Year | $186.30 | $8.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.66 |
| 52 Week Low | $3.95 | $1.65 |
| 52 Week High | $34.27 | $5.19 |
| Indicator | SCLX | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 46.60 |
| Support Level | $6.20 | $1.67 |
| Resistance Level | $7.77 | $2.03 |
| Average True Range (ATR) | 0.72 | 0.11 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 71.43 | 23.68 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.